期刊文献+

端粒酶反义寡核苷酸体外抑制宫颈癌细胞端粒酶活性的研究 被引量:4

Inhibition of telomerase antisense oligonucleotides on telomerase activity of cervical carcinoma cell in vitro
下载PDF
导出
摘要 目的探讨端粒酶反义寡核苷酸(ASON)对宫颈癌Hela细胞端粒酶活性的影响。方法针对端粒酶RNA的ASON作用于Hela细胞,同时以加有转染剂FuGENE6者为对照组,计数连续作用1,3,5 d后的细胞数。TRAP方法测定端粒酶的活性。结果ASON组与随机引物及空白对照组比较,端粒酶活性降低,细胞的增殖速度延缓;有转染剂FuGENE6的ASON组的细胞增殖数目和端粒酶活性显著低于无FuGENE6的ASON组;细胞对有FuGENE6的ASON的摄取显著多于单纯的ASON。在FuGENE6的介导下,ASON对端粒酶活性的抑制与ASON的浓度和治疗时间呈正相关。结论针对端粒酶RNA的ASON能抑制Hela细胞的端粒酶活性,转染剂FuGENE6可以增强端粒酶ASON对宫颈癌细胞端粒酶活性的抑制作用。 Objectives: To investigate the effects of telomerase antisense oligonucleotides on telomerase activity of cervical carcinoma Hela cells. Methods: Hela cells were treated by antisense oligonucleotides targeted to the RNA temp late region of telomerase and oligonucleotide with FuGENE6 was observed as controls. Number of the cells was counted from 1 to 5 days. The telomerase aitivity was performed using PCR-TRAP. Results: The ASON reduced the telomerase activity and number of cells compared with the random primer and the empty controls. The ASON with FuGENE6 inhibited the telomerase activity and Hela cells growth more efficiently than the ASON without FuGENE6 and the efficiency depended on the dose of ASON and the time of treatment. Conclusions: ASON targeted the RNA template region of telomerase inhibite the telomerase activity of Hela cells; Transfection regant FuGENE6 enhance the efficiency of inhibition.
作者 马艳 陈忠东
出处 《中国现代医学杂志》 CAS CSCD 2004年第24期61-63,共3页 China Journal of Modern Medicine
关键词 端粒酶 转染荆 宫颈癌 反义寡核苷酸 telomerase transfectionregant cervicalcarcinoma antisenseoligonucleotides
  • 相关文献

参考文献11

二级参考文献26

  • 1Greider CW. Mammalian telomere dynamics: healing, fragmentation shortening, and stabilization [J]. Curr Op. Genet and Dev, 1994, 4: 203-211.
  • 2Rgu MS. Telomere, telomerase and immotality [J]. J Natl Cancer lnst, 1995, 87: 884-894.
  • 3Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase [J]. Science, 1995, 269: 1236-1241.
  • 4Blasco MA, Rizen M, Greider CW, et al. Differential regulation of telomerase activity and telomerase RNA during multistage tumorrigenesis [J]. Nature Genet, 1996, 12: 200-204.
  • 5Savoysky E, Yoshida K, Ohtomo T, et al. Down-regulation of telomerase activity is an early event in the differentiation of HL60 cells [J]. Biochem Biophys Res Commun, 1996,226 : 329-334.
  • 6Landman J, Kavaler E, Dvoller MJ. Application of telomerase in urologic oncology [J]. World J Urol, 1997, 15: 120-124.
  • 7Kondo S, Tanaka Y, Kondo Y, et al. Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation [J]. FASEB-J, 1998, 12: 801-811.
  • 8Blackburn EH. Structure and function of telomere[J]. Nature,1995, 350: 569-573.
  • 9Sommerfeld HJ, McCker AK, Piatyszck MA, et al. Telomerase activity:a prevalent marker of malignant human prostate tissue. Cancer Res, 1996, 56(6):218.
  • 10Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast turmors. J Natl Cancer Inst, 1997,89(6):437.

共引文献21

同被引文献29

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部